Riverside has sold Diatron to Stratec Biomedical

Client: The Riverside Company

Client Location: United States of America

Buyer: Stratec Biomedical AG

Buyer Location: Germany

Target: Diatron Group

Target Location: Hungary

Target Description: The Diatron Group is a hematology and clinical chemistry analyzer and reagent manufacturer.

Riverside Diatron Stratec 2016
  • 2016
    Close Year
  • Healthcare
  • Private Equity
    Client Type
  • Strategic | Cross-border
    Transaction Type
  • USA | Germany | Hungary

Meet our Senior Team